Skip to content
Menu

Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $320

Benzinga Newsdesk 9 hours ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $275 to $320.

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $275 to $320.

Read at benzinga.com